Review of the New Delayed‐Release Oral Tablet and Intravenous Dosage Forms of Posaconazole

E-ISSN： 1875-9114|35|2|208-219

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.2, 2015-02, pp. : 208-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet

By Garikipati Vandana Toops Dana S. Fang Qi

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1869-1876

Informa Healthcare

Access to resources Recommend Favorite

Use of posaconazole delayed‐release tablets for treatment of invasive aspergillosis

MYCOSES (ELECTRONIC), Vol. 58, Iss. 5, 2015-05 ,pp. : 313-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of oral posaconazole on the pharmacokinetics of sirolimus

By Moton Allen Ma Lei Krishna Gopal Martinho Monika Seiberling Michael McLeod James

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 701-707

Informa Healthcare

Access to resources Recommend Favorite

Posaconazole: A New Antifungal Weapon

Reviews on Recent Clinical Trials, Vol. 6, Iss. 3, 2011-09 ,pp. : 204-219

Bentham Science Publishers

Access to resources Recommend Favorite

Posaconazole liquid vs tablet formulation in lung transplant recipients

MYCOSES (ELECTRONIC), Vol. 61, Iss. 3, 2018-03 ,pp. : 186-194

John Wiley & Sons Inc

Access to resources Recommend Favorite